Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 7—July 2022
Dispatch

Anncaliia algerae Microsporidiosis Diagnosed by Metagenomic Next-Generation Sequencing, China

Chen Liu1, Qin Chen1, Ping Fu, and Yun-Ying ShiComments to Author 
Author affiliations: West China Hospital of Sichuan University, Chengdu, China (C. Liu, Q. Chen, P. Fu, Y.-Y. Shi); Chengdu 363 Hospital of Southwest Medical University, Chengdu (Q. Chen)

Main Article

Table

Clinical characteristics of 12 previously reported cases of human Anncaliia algerae microsporidia infection*

Case reports
 Age, y/sex
 Immunocompromised/underlying conditions
 Related symptoms
 Positive biopsy sample sites
 Treatment
 Outcome
Watts et al. 2014 (1) 67/M Y/RA Myalgias Vastus lateralis Albendazole Survived
66/M
 Y/RA
 Myalgias
 Vastus lateralis
 NG
 Died
Coyle et al. 2004 (2)
 57/F
 Y/RA
 Myalgias
 Quadriceps femoris
 Albendazole
 Died
Boileau et al. 2016 (3)
 49/M
 Y/CLL
 Myalgias
 Vastus lateralis
 Albendazole and fumagillin
 Survived
Sutrave et al. 2018 (4)
 66/M
 Y/GVHD
 Myalgias
 Vastus lateralis
 Albendazole
 Survived
Visvesvara et al. 1999 (5)
 67/M
 N/N
 Eye discomfort
 Cornea
 Albendazole and fumagillin
 Survived
Ziad et al. 2021 (6)
 55/M
 Y/psoriatic arthritis
 Myalgias
 Vastus lateralis, intercostal muscle, and tongue
 Albendazole
 Died
Visvesvara et al. 2005 (7)
 11/M
 Y/ALL
 Skin lesions
 Skin
 NA
 NA
Cali et al. 2010 (8)
 69/M
 Y/CLL
 Hoarseness
 False vocal cord
 Albendazole
 Died
Field et al. 2012 (9)
 49/F
 Y/lung transplant
 Myalgias
 Deltoid and tongue
 NG
 Died
Chacko et al. 2013 (10)
 56/M
 Y/kidney transplant
 Myalgias
 Deltoid
 Albendazole
 Died
Anderson et al. 2019 (11) 60/M Y/kidney and pancreas transplant Skin lesions Lower extremity, finger, tongue, urine, and
sputum		 Albendazole Died

*ALL, acute lymphoblastic leukemia; CLL, chronic lymphocytic leukemia; GVHD, graft-versus-host disease; NA, data not available; NG, treatment for A. algerae was not given because the patient was undiagnosed before death; RA, rheumatoid arthritis.

Main Article

References
  1. Watts  MR, Chan  RCF, Cheong  EYL, Brammah  S, Clezy  KR, Tong  C, et al. Anncaliia algerae microsporidial myositis. Emerg Infect Dis. 2014;20:185–91. DOIPubMedGoogle Scholar
  2. Coyle  CM, Weiss  LM, Rhodes  LV III, Cali  A, Takvorian  PM, Brown  DF, et al. Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N Engl J Med. 2004;351:42–7. DOIPubMedGoogle Scholar
  3. Boileau  M, Ferreira  J, Ahmad  I, Lavallée  C, Qvarnstrom  Y, Dufresne  SF. Successful treatment of disseminated Anncaliia algerae microsporidial infection with combination fumagillin and albendazole. Open Forum Infect Dis. 2016;3:ofw158. DOIPubMedGoogle Scholar
  4. Sutrave  G, Maundrell  A, Keighley  C, Jennings  Z, Brammah  S, Wang  M-X, et al. Anncaliia algerae microsporidial myositis, New South Wales, Australia. Emerg Infect Dis. 2018;24:1528–31. DOIPubMedGoogle Scholar
  5. Visvesvara  GS, Belloso  M, Moura  H, Da Silva  AJ, Moura  IN, Leitch  GJ, et al. Isolation of Nosema algerae from the cornea of an immunocompetent patient. J Eukaryot Microbiol. 1999;46:10S.PubMedGoogle Scholar
  6. Ziad  F, Robertson  T, Watts  MR, Copeland  J, Chiu  G, Wang  D, et al. Fatal disseminated Anncaliia algerae myositis mimicking polymyositis in an immunocompromised patient. Neuromuscul Disord. 2021;31:877–80. DOIPubMedGoogle Scholar
  7. Visvesvara  GS, Moura  H, Leitch  GJ, Schwartz  DA, Xiao  LX. Public health importance of Brachiola algerae (Microsporidia)—an emerging pathogen of humans. Folia Parasitol (Praha). 2005;52:83–94. DOIPubMedGoogle Scholar
  8. Cali  A, Neafie  R, Weiss  LM, Ghosh  K, Vergara  RB, Gupta  R, et al. Human vocal cord infection with the Microsporidium Anncaliia algerae. J Eukaryot Microbiol. 2010;57:562–7. DOIPubMedGoogle Scholar
  9. Field  AS, Paik  JY, Stark  D, Qiu  MR, Morey  A, Plit  ML, et al. Myositis due to the microsporidian Anncaliia (Brachiola) algerae in a lung transplant recipient. Transpl Infect Dis. 2012;14:169–76. DOIPubMedGoogle Scholar
  10. Chacko  B, Trevillian  P. Microsporidial myositis in a kidney transplant recipient [abstract 82]. In: Program and abstracts of Annual Scientific Meeting Transplantation Society of Australia and New Zealand. Canberra (ACT, Australia): Transplantation Society of Australia and New Zealand; 2013. p. 96.
  11. Anderson  NW, Muehlenbachs  A, Arif  S, Bruminhent  J, Deziel  PJ, Razonable  RR, et al. A fatal case of disseminated microsporidiosis due to Anncaliia algerae in a renal and pancreas allograft recipient. Open Forum Infect Dis. 2019;6:ofz285. DOIPubMedGoogle Scholar
  12. Franzen  C, Müller  A. Microsporidiosis: human diseases and diagnosis. Microbes Infect. 2001;3:389–400. DOIPubMedGoogle Scholar
  13. Chiu  CY, Miller  SA. Clinical metagenomics. Nat Rev Genet. 2019;20:341–55. DOIPubMedGoogle Scholar
  14. Costa  SF, Weiss  LM. Drug treatment of microsporidiosis. Drug Resist Updat. 2000;3:384–99. DOIPubMedGoogle Scholar

Main Article

1These first authors contributed equally to this article.

Page created: May 16, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external